by: Parent Project Muscular DystrophyResults from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017)
Parent Project Muscular Dystrophy, Coalition Duchenne, and Capricor hosted a webinar on April 28, 2017 to hear a community update on the six-month results from Capricor’s randomized Phase I/II HOPE Clinical Trial of CAP-1002 (allogeneic cardiosphere-derived cells), an investigational candidate for the treatment of Duchenne.
